Le Lézard
Classified in: Health
Subject: TRI

Study Shows True Chiropractic Manipulation Improves OVX-Related Bone Loss in Rats


PHOENIX, Oct. 20, 2017 /PRNewswire/ -- For years, chiropractors have used chiropractic manipulation to create positive effects for many patients. A recent study, first published in Calcified Tissue International, offers new, empirical data looking specifically at the effect of chiropractic manipulation on levels of osteoporotic bone loss. The study opens new options for research and application of chiropractic manipulation for a growing patient group suffering from bone density changes related to aging or other factors.

Study Overview

For the study, researchers in Spain created a variety of test groups of 6-month old Sprague-Dawley rats. A first test group underwent an ovariectomy (OVX) operation, while a second test group underwent a sham operation. Both groups were further divided into sub-groups receiving true chiropractic manipulation with the Activator V® (TM), false manipulation (FM), or no manipulation (NM).

Throughout the study, bone mineral density (BMD), bone mineral content (BMC), mechano growth factors (MGF), and bone densitometry (DXA) were measured and calculated for all subjects.

Results

The data findings of the study show that true chiropractic manipulation improves OVX-related bone loss in rats. More specifically, Activator V® adjustment in the tibial tubercle of the hind limb produced higher BMD and BMC in both the distal femur and the proximal tibia of OVX-TM rats.

Going further, the study also looks at whether the improvement in bone mass for OVX rats is related to parallel changes in bone structure elicited by chiropractic manipulation. Relative to the FM and NM sub-groups, data for the OVX groups receiving true manipulation shows a significant improvement of these bone structure parameters (BV/TV, Tb.N and Tb.S) at all studied skeletal locations.

Finally, the study considers how chiropractic manipulation might impact MGF protein expressions in the muscle systems of the rats. Higher levels of MGF protein occurred in the skeletal muscles of the OVX-TM rats compared to the OVX-FM rats, confirming the local action of Activator V® in counteracting the low muscle MGF protein expression in OVX rats.

In conclusion, the findings of this study support the notion that true chiropractic manipulation can improve the osteoporotic bone at least in part by targeting skeletal muscle. This supports research into new avenues in true application of chiropractic manipulation in bone loss-related situations.

About Activator

Activator Methods International® is home to the full line of Activator® instruments and the ActivatorMethod® of chiropractic instrument adjusting. Founded on the principles of clinical research, Activator Methods International has been providing chiropractic care, resources and training since 1967. For more information please visit www.activator.com.

To view the full article visit activator.com/research. For more information, please contact Kevin Green at [email protected] or call 1-800-441-5571.

 

SOURCE Activator Methods International


These press releases may also interest you

at 10:54
Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of OBGEMSAtm (vibegron under the international...

at 10:49
Sustain Exchange LLC is proud to announce a partnership with HearMe, a leading behavioral health peer support platform focused on ensuring healthy lives and promoting well-being. As part of this innovative partnership, SustainAble Exchange will...

at 10:45
C?N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today announced a partnership agreement with Mediford Corporation, a PHC Holdings Corporation (TSE 6523) Group Company and premier...

at 10:35
BeiGene, Ltd. , a global oncology company, released its 2023 Responsible Business & Sustainability Report highlighting the Company's strategy, the progress it has made towards existing goals, and how it intends to achieve its bold new targets. This...

at 10:30
Invensify, Inc., Santa Clara, California, has introduced a power efficient, temperature-controlled shipping container designed to maintain stable storage temperatures for high-value pharmaceuticals before and during transport to last-mile cold chain...

at 10:30
Oligonucleotide Synthesis Market in terms of revenue was estimated to be worth $8.8 billion in 2024 and is poised to reach $19.7 billion by 2029, growing at a CAGR of 17.5% from 2024 to 2029 according to a new report by MarketsandMarketstm. One of...



News published on and distributed by: